XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.1
Condensed Consolidated Statements of Earnings and Comprehensive Income (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Income Statement [Abstract]        
Net sales $ 1,809 $ 1,781 $ 5,306 $ 5,539
Cost of products sold 1,160 1,007 3,429 3,008
Gross profit 649 774 1,877 2,531
Selling and administrative expenses 233 237 710 744
Advertising costs 153 200 502 566
Research and development costs 31 32 98 104
Goodwill, trademark and other asset impairments 0 329 0 329
Interest expense 21 25 69 74
Other (income) expense, net 11 10 20 (85)
Earnings (losses) before income taxes 200 (59) 478 799
Income taxes 48 0 111 180
Net earnings (losses) 152 (59) 367 619
Less: Net earnings attributable to noncontrolling interests 2 2 6 6
Net earnings (losses) attributable to Clorox $ 150 $ (61) $ 361 $ 613
Net earnings (losses) per share attributable to Clorox        
Basic net earnings (losses) per share (in dollars per share) $ 1.22 $ (0.49) $ 2.93 $ 4.86
Diluted net earnings (losses) per share (in dollars per share) $ 1.21 $ (0.49) $ 2.91 $ 4.78
Weighted average shares outstanding (in thousands)        
Basic (in shares) 123,177 125,610 123,074 126,057
Diluted (in shares) 123,877 125,610 123,943 128,030
Comprehensive income (loss) $ 207 $ (37) $ 394 $ 706
Less: Total comprehensive income attributable to noncontrolling interests 2 2 6 6
Total comprehensive income (loss) attributable to Clorox $ 205 $ (39) $ 388 $ 700